Lo Biosciences, Inc.

Lo Biosciences, Inc. is a minority-owned, for-profit biotechnology company based in Rockville, MD, specializing in diagnostic technologies and point-of-care testing solutions for infectious diseases. The company focuses on developing innovative diagnostic devices and technologies that enable more accessible and efficient medical testing, particularly for challenging infectious diseases like HIV and hepatitis C. Registered in SAM.gov since October 2018, Lo Biosciences, Inc. has demonstrated a strategic approach to developing advanced medical diagnostic solutions that address critical public health challenges.

The company has secured federal grant awards primarily from the Centers for Disease Control and Prevention (CDC) and the National Science Foundation (NSF), focusing on developing advanced blood separation and diagnostic testing technologies. Its most recent significant award is a $994,658 project grant from the CDC's Investigations and Technical Assistance program, aimed at creating a novel remote blood separation device for at-home plasma collection to enable HIV-1 testing. Previously, Lo Biosciences, Inc. was involved in a cooperative agreement with the NSF's Technology, Innovation, and Partnerships program to develop blood-plasma separation technologies for point-of-care diagnostic testing. The company's work consistently demonstrates a commitment to creating low-cost, efficient systems for robust diagnostic testing, with a particular emphasis on improving detection methods for infectious diseases like HIV and hepatitis C. Their technological innovations seek to overcome current limitations in blood testing by developing alternative sample collection and processing methods that can be used in diverse clinical settings.